LifeMD, Inc. (LFMDP) vs NervGen Pharma Corp. Common stock (NGEN)
A side-by-side comparison of LifeMD, Inc. and NervGen Pharma Corp. Common stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LFMDP
LifeMD, Inc.
$21.70HealthcareDelayed quote: Oct 6, 2026, 11:23 AM EDT
NGEN
NervGen Pharma Corp. Common stock
$1.81HealthcareDelayed quote: Oct 6, 2026, 11:44 AM EDT
Total return — LFMDP vs NGEN
growth of $100 · dividends reinvested · last 1yLFMDP +11.1% (+11.1%/yr)NGEN -57.6% (-57.6%/yr)LFMDP compounded faster over this window
LFMDP NGEN
LFMDP vs NGEN: by the numbers
- •NGEN is the larger company ($148M vs $148M market cap).
- •Both run net losses; NGEN's is the smaller (0.00% vs -10.40% net margin).
- •LFMDP pays a dividend (9.71% yield), while NGEN has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | LFMDP | NGEN |
|---|---|---|
| P/S ratio | 0.72 | N/A |
| P/B ratio | 18.57 | 12.19 |
Profitability
| Metric | LFMDP | NGEN |
|---|---|---|
| Gross margin | 85.91% | 0.00% |
| Operating margin | -9.35% | 0.00% |
| Net margin | -10.40% | 0.00% |
| ROE | -266.86% | -397.38% |
| ROIC | -143.97% | -223.90% |
Dividends
| Metric | LFMDP | NGEN |
|---|---|---|
| Dividend yield | 9.71% | N/A |
Growth (annualized)
| Metric | LFMDP | NGEN |
|---|---|---|
| Revenue CAGR (5Y) | 26.00% | N/A |
| Total return CAGR (5Y) | 10.80% | N/A |
Frequently asked
- Does LFMDP or NGEN pay a bigger dividend?
- LFMDP pays a dividend (9.71% yield), while NGEN has no payments in the available dividend history.
Go deeper
Dig into the metrics
LifeMD dividend yieldLifeMD ROENervGen Pharma Corp. Common stock ROELifeMD operating marginNervGen Pharma Corp. Common stock operating marginLifeMD revenue growthNervGen Pharma Corp. Common stock revenue growthLifeMD free cash flowNervGen Pharma Corp. Common stock free cash flow
LifeMD & NervGen Pharma Corp. Common stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.